Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by JG Treleaven
Recombinant Tissue Plasminogen Activator (rtPA) for the Treatment of Hepatic Veno-Occlusive Disease (VOD)
Bone Marrow Transplantation
Transplantation
Hematology
Related publications
Hepatic Veno-Occlusive Disease: Report of a Case
Jornal de Pediatria
Child Health
Pediatrics
Perinatology
Recent Developments With Defibrotide for the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome
Expert Opinion on Orphan Drugs
Toxicology
Pharmaceutics
Pharmacology
Health Policy
Compatibility of Recombinant Tissue Plasminogen Activator (rtPA) and Aflibercept or Ranibizumab Coapplied for Neovascular Age-Related Macular Degeneration With Submacular Haemorrhage
British Journal of Ophthalmology
Molecular Neuroscience
Ophthalmology
Sensory Systems
Cellular
Phase I Study of Intraventricular Recombinant Tissue Plasminogen Activator for Treatment of Posthaemorrhagic Hydrocephalus.
Archives of Disease in Childhood: Fetal and Neonatal Edition
Pediatrics
Gynecology
Perinatology
Obstetrics
Medicine
Child Health
Low Molecular Weight Heparin for the Prevention of Hepatic Veno-Occlusive Disease (VOD) After Hematopoietic Stem Cell Transplantation: A Prospective Phase II Study
Bone Marrow Transplantation
Transplantation
Hematology
Expanding Recombinant Tissue Plasminogen Activator Time Window Is Premature
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
Pulmonary Veno-Occlusive Disease
Acta Medica Scandinavica
Defibrotide – A New Treatment Approach for Severe Veno-Occlusive Disease
European Oncology and Haematology
Oncology
Hematology
Pulmonary Veno-Occlusive Disease
The Lancet
Medicine
